As shown in Fig. 3a, H&E staining showed that TAC induced cardiac hypertrophy, but AGGF1 protein therapy resulted in less enlargement of the hearts compared with phosphate-buffered saline (PBS) treatment. The gene discussed is AGGF1; the disease is persistent truncus arteriosus.